Genetic Screens: A Route to Rapid Progress in Disease Targeting and Drug Development

Category: Research Services


In association with The Scientist®

Genetic screens are powerful techniques to investigate gene function, dissect complex biological processes, and rapidly assess drug targets. Advances in CRISPR/Cas9 technology have led to remarkable progress in this relatively new field. The Scientist brings together a panel of experts to share their perspectives on genome-wide functional screening and applications in drug development. Attendees can interact with the panel during the live webinar by asking questions and sharing their experiences.

Dr. Feng Zhang
Core Member, Broad Institute of MIT and Harvard, Keck Career Development Professor
Massachusetts Institute of Technology

Dr. Traver Hart
Assistant Professor, Department of Bioinformatics and Computational Biology
MD Anderson Cancer Center

Topics to be covered:

  • Application of genome-scale gain- and loss-of-function screening using the CRISPR system
  • Identification of biomarkers associated with genetic vulnerabilities in genome-scale knockout screens
  • Use of synthetic drug screens to evaluate drug efficacy in different tumor mutational backgrounds

Register Now


CRISPR Drug Development

Back to top